Bellicum Pharmaceuticals EHA Presentation Helps Validate Its Platform – Benzinga
Benzinga |
Bellicum Pharmaceuticals EHA Presentation Helps Validate Its Platform
Benzinga The firm said this could have broader applicability in controlling and optimizing the therapeutic index of other cell therapies, like CAR–T cells and eTCR therapeutics in its pipeline. Meanwhile, as a new standard of care, the firm said the combination … |
